PeDRA 2025Abstract 068Clinical trial
Pharmacokinetics (PK) and safety of tralokinumab in children (aged 6 to <12 years) with moderate-to-severe atopic dermatitis
an interim analysis of the TRAPEDS 1 phase 2 trial
Cork M, de Graaf M, Torres EB, Pasmans S, Reguiai Z, Kurvits M, Lo H, Schneider S, Søhoel A, Thøgersen P, Flohr C, Eichenfield LF
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Atopic dermatitis & eczemaPediatric dermatology
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00604-4 · Not in PubMed: details from Crossref